Webinar: an international One Health perspective on Q fever and coxiellosis:

 The webinar is co-hosted by Sydney ID, the Australasian Society of Infectious Diseases (ASID), the Australian Veterinarians in Public Health (AVA-AVPH) and Queensland Health.

30 March 2023, 7.30PM - 9.00PM

An outbreak of a febrile illness among workers in an abattoir in Queensland, Australia, investigated in 1933 by Edward Derrick led to him coining the name "Q fever" to the syndrome with the "Q"standing for Query because there were so many unanswered questions about the disease. We now know Q fever is caused by the bacterial pathogen, Coxiella burnetii, that livestock are the most important reservoir for the disease in Australia, and that Q fever occurs around the globe, but many questions about this disease remain unanswered 90 years later.

To celebrate the 90th anniversary of the first reports of this disease, this webinar will discuss international research into Q fever as well as some updates on what is happening here in Australia to address some of the queries about this fascinating disease.

Register here

Impact of Coxiella burnetii vaccination on humoral immune response, vaginal shedding, and lamb mortality in naturally pre-infected sheep

Introduction: Sheep are considered to be one of the main reservoirs for Coxiella burnetii, a gram-negative bacterium with high zoonotic potential. Infected sheep shed tremendous amounts of the pathogen through birth products which caused human Q fever epidemics in several countries. Information about the impact of an inactivated C. burnetii Phase I vaccine on humoral immune response, vaginal shedding, and lamb mortality in naturally pre-infected sheep is scarce.

Methods: Two identically managed and naturally C. burnetii-infected sheep flocks were examined for two lambing seasons (2019 and 2020). One flock (VAC) received a primary vaccination against Q fever before mating and the second flock served as control (CTR). In each flock, one cohort of 100 ewes was included in follow-up investigations. Serum samples at eight different sampling dates were analyzed by C. burnetii phase-specific ELISAs to differentiate between the IgG Phase I and II responses. Vaginal swabs were collected within three days after parturition and examined by a C. burnetii real-time PCR (IS1111). Lamb losses were recorded to calculate lamb mortality parameters.

Results: After primary vaccination, almost all animals from cohort VAC showed a high IgG Phase I response up until the end of the study period. In cohort CTR, the seropositivity rate varied from 35.1% to 66.3%, and the Phase I and Phase II pattern showed an undulating trend with higher IgG Phase II activityduring both lambing seasons. The number of vaginal shedders was significantly reduced in cohort VAC compared to cohort CTR during the lambing season in 2019 (p < 0.0167). There was no significant difference of vaginal shedders in 2020. The total lamb losses were low in both cohorts during the two investigated lambing seasons (VAC 2019: 6.8%, 2020: 3.2%; CTR 2019: 1.4%,2020: 2.7%).

Discussion: Neither the C. burnetii vaccine nor the C. burnetii infection seem to have an impact on lamb mortality. Taken together, the inactivated C. burnetii Phase I vaccine induced a strong IgG Phase I antibody response in naturally pre-infected sheep. It might also reduce vaginal shedding in the short term but seems to have little beneficial impact on lamb mortality.

Source: Bauer et al., Frontiers in Veterinary Science 01 frontiersin.org, 10.3389/fvets.2022.1064763

READ FULL ARTICLE

TGF-β/IFN-γ Antagonism in Subversion and Self-Defense of Phase II Coxiella burnetii-Infected Dendritic Cells

 Dendritic cells (DCs) belong to the first line of innate defense and come into early contact with invading pathogens, including the zoonotic bacterium Coxiella burnetii, the causative agent of Q fever. However, the pathogen-host cell interactions in C. burnetii-infected DCs, particularly the role of mechanisms of immune subversion beyond virulent phase I lipopolysaccharide (LPS), as well as the contribution of cellular self-defense strategies, are not understood. Using phase II Coxiella-infected DCs, we show that impairment of DC maturation and MHC I downregulation is caused by autocrine release and action of immunosuppressive transforming growth factor-β (TGF-β). Our study demonstrates that IFN-γ reverses TGF-β impairment of maturation/MHC I presentation in infected DCs and activates bacterial elimination, predominantly by inducing iNOS/NO. Induced NO synthesis strongly affects bacterial growth and infectivity. Moreover, our studies hint that Coxiella-infected DCs might be able to protect themselves from mitotoxic NO by switching from oxidative phosphorylation to glycolysis, thus ensuring survival in self-defense against C. burnetii. Our results provide new insights into DC subversion by Coxiella and the IFN-γ-mediated targeting of C. burnetii during early steps in the innate immune response.

Source: Matthiesen S, Christiansen B, Jahnke R, Zaeck LM, Karger A, Finke S, Franzke K, Knittler MR. Infect Immun. 2023 Jan 23:e0032322. doi: 10.1128/iai.00323-22. Online ahead of print. PMID: 36688662

READ ABSTRACT

The European Union One Health 2021 Zoonoses Report

 Q Fever – Key Facts

•  In 2021, the number of confirmed cases of human Q fever was 460 corresponding to an EU notification rate of 0.11 per 100,000 population. This is a decrease of 12.0% compared with the rate in 2020 (0.12 per 100,000 population).
• Compared with the rate before the COVID-19 pandemic (2017–2019 annual mean), there was a decrease of 38.8% and 45.8% with or without data from the United Kingdom
• Over the past 5 years (2017–2021), a significant decreasing trend (p < 0.05) in the number of Q fever cases was observed.
• In 2021, Q fever cases occurred from April to September, in line with the spring/summer seasonal pattern. Cases were highest for the 50–55 years age group.
• In animals, cattle and small ruminants were mostly sampled during clinical investigations and passive monitoring of animals suspected to be infected with Coxiella burnetii. However, in the absence of harmonised reporting data in animals in the EU, the data reported to EFSA cannot be used to analyse spatial representativeness and trends over the years for Q fever at the EU level or to compare differences among reporting countries.
• In total, 17 MSs (15 in 2020) and five non-MSs (six in 2020) reported 2021 data for
  C. burnetii. The proportion of positive animals with direct tests was 5.9% in sheep (8.7% in 2020), 16.5% in goats (11.3% in 2020) and 5.2% in cattle (3.8% in 2020).The proportion of positive herds with direct tests was 4.1% in sheep (1.4% in 2020), 2.0% in goats (1.2% in 2020) and 4.8% in cattle (6.7% in 2020). The proportion of seropositive animals was 10.3% in sheep (11.4% in 2020), 24.6% in goats (25.0% in 2020) and 12.2% in cattle (9.6% in 2020). The proportion of seropositive herds was 18.9% in sheep (5.9% in 2020), 50.0% in goats (78.7% in 2020) and 15.1% in cattle (14.4% in 2020). Results from various other domestic
  and wild animal species were reported and only Italy reported positive results, mainly from dogs (73.2% out of 541) and water buffalos (4.7% out of 43).

Adapted from European Union One Health 2021 Zoonoses Report, © European Food Safety Authority.

EFSA Journal 2022;20(12):7666, DOI: The European Union One Health 2021 Zoonoses Report
Q Fever – Key Facts

• In 2021, the number of confirmed cases of human Q fever was 460 corresponding to an EU notification rate of 0.11 per 100,000 population. This is a decrease of 12.0% compared with the rate in 2020 (0.12 per 100,000 population).
• Compared with the rate before the COVID-19 pandemic (2017–2019 annual mean), there was a decrease of 38.8% and 45.8% with or without data from the United Kingdom
• Over the past 5 years (2017–2021), a significant decreasing trend (p < 0.05) in the number of Q fever cases was observed.
• In 2021, Q fever cases occurred from April to September, in line with the spring/summer seasonal pattern. Cases were highest for the 50–55 years age group.
• In animals, cattle and small ruminants were mostly sampled during clinical investigations and passive monitoring of animals suspected to be infected with Coxiella burnetii. However, in the absence of harmonised reporting data in animals in the EU, the data reported to EFSA cannot be used to analyse spatial representativeness and trends over the years for Q fever at the EU level or to compare differences among reporting countries.
• In total, 17 MSs (15 in 2020) and five non-MSs (six in 2020) reported 2021 data for
C. burnetii. The proportion of positive animals with direct tests was 5.9% in sheep (8.7% in 2020), 16.5% in goats (11.3% in 2020) and 5.2% in cattle (3.8% in 2020).The proportion of positive herds with direct tests was 4.1% in sheep (1.4% in 2020), 2.0% in goats (1.2% in 2020) and 4.8% in cattle (6.7% in 2020). The proportion of seropositive animals was 10.3% in sheep (11.4% in 2020), 24.6% in goats (25.0% in 2020) and 12.2% in cattle (9.6% in 2020). The proportion of seropositive herds was 18.9% in sheep (5.9% in 2020), 50.0% in goats (78.7% in 2020) and 15.1% in cattle (14.4% in 2020). Results from various other domestic
and wild animal species were reported and only Italy reported positive results, mainly from dogs (73.2% out of 541) and water buffalos (4.7% out of 43).
Adapted from European Union One Health 2021 Zoonoses Report, © European Food Safety Authority).

EFSA Journal 2022;20(12):7666, DOI: https://doi.org/10.2903/j.efsa.2022.7666
Author: European Food Safety Authority and European Centre for Disease Prevention and Control (EFSA and ECDC), Q Fever, p. 222 – 230, published 13th December 2022

Download European Union One Health 2021 Zoonoses Report

New Flyer "Q Fever – More than a flu" Information for the general population on Q Fever in humans available for download

Q fever can be easily mixed up with a summer flu, as the disease often begins with high temperature up to 40 degrees Celsius, chills, head aches, aching limbs and weariness. The disease which is transferred among others by sheep and goats is rarely identified. However, the effects of an unidentified infection can be potentially severe and even deadly. Another frequently neglected consequence of acute infection can be a Post Q Fever Fatigue Syndrome.

Surveillance of Coxiella burnetii Shedding in Three Naturally Infected Dairy Goat Herds after Vaccination, Focusing on Bulk Tank Milk and Dust Swabs

Q fever outbreaks on three dairy goat farms (A–C) were monitored after the animals had been vaccinated with an inactivated Coxiella burnetii phase I vaccine. The antibody response was measured before vaccination by serum samples with two C. burnetii phase-specific ELISAs to characterize the disease status. Shedding was determined by vaginal swabs during three kidding seasons and monthly bulk tank milk (BTM) samples. Dust swabs from one windowsill of each barn and from the milking parlors were collected monthly to evaluate the indoor exposure.

These samples were analyzed by qPCR. The phase-specific serology revealed an acute Q fever infection in herd A, whereas herds B and C had an ongoing and past infection, respectively. In all three herds, vaginal shedders were present during three kidding seasons. In total, 50%, 69%, and 15% of all collected BTM samples were C. burnetii positive in herds A, B, and C, respectively. Barn dust contained C. burnetii DNA in 71%, 45%, and 50% of examined swabs collected from farms A, B, and C, respectively. The largest number of C. burnetii positive samples was obtained from the milking parlor (A: 91%, B: 72%, C: 73%), indicating a high risk for humans to acquire Q fever during milking activity.

Abstract taken from: Benjamin U Bauer, Clara Schoneberg, T Louise Herms, Martin Runge, Martin Ganter, Surveillance of Coxiella burnetii Shedding in Three Naturally Infected Dairy Goat Herds after Vaccination, Focusing on Bulk Tank Milk and Dust Swabs, Vet Sci. 2022 Feb 24;9(3):102. doi: 10.3390/vetsci9030102.

Read full article

Q fever expertise among human and veterinary health professionals in Germany – A stakeholder analysis of knowledge gaps

Q fever is a zoonosis caused by Coxiella burnetii. In Germany, the common sources of human infections include small ruminants that excrete the pathogen. Q fever in humans can be asymptomatic or nonspecific. However, severe disease progression is also possible, which can lead to death. Q fever in small ruminants is usually asymptomatic, although reproductive disorders may occur. To protect humans from Q fever, it is important that human and veterinary health professionals (practitioners/health authority employees) have comprehensive knowledge of the diagnosis, control and prevention of Q fever, and its zoonotic potential. To ensure and enhance this understanding, this stakeholder analysis assessed Q fever expertise in human and veterinary health professionals in Germany and investigated how these knowledge gaps can best be resolved.

For this purpose, an online survey and two focus group discussions were conducted with 836 and 18 participants, respectively. Knowledge gaps are due to a lack of awareness of Q fever, especially among human health practitioners. Moreover, colleagues who have heard about Q fever still lack the necessary cross-species knowledge to successfully diagnose, control and prevent this zoonosis. Additionally, differences exist between stakeholders regarding their work context and the region in which they work. In this study, stakeholders in southwestern Germany had slightly better Q fever knowledge than their colleagues in North-eastern Germany.

In addition, information sources aimed at resolving knowledge gaps involve direct conversations between the stakeholders, as well as reading materials and seminars. Each of these information sources should focus on interdisciplinary resources to strengthen the cooperation between human and veterinary health professionals and to raise awareness of the strengths of each stakeholder group. These results have already been implemented by the Q-GAPS project, with goals of raising awareness of Q fever and filling knowledge gaps.

Abstract taken from: Fenja Winter und Amely Campe, A stakeholder analysis of knowledge gaps, PLoS One, 2022 Mar 3;17(3):e0264629.

READ FULL ARTICLE

The Coxiella burnetii T4SS effector protein AnkG hijacks the 7SK small nuclear ribonucleoprotein complex for reprogramming host cell transcription

Inhibition of host cell apoptosis is crucial for survival and replication of several intracellular bacterial pathogens. To interfere with apoptotic pathways, some pathogens use specialized secretion systems to inject bacterial effector proteins into the host cell cytosol. One of these pathogens is the obligate intracellular bacterium Coxiella burnetii, the etiological agent of the zoonotic disease Q fever.

In this study, we analyzed the molecular activity of the anti-apoptotic T4SS effector protein AnkG (CBU0781) to understand how C. burnetii manipulates host cell viability. We demonstrate by co- and RNA-immunoprecipitation that AnkG binds to the host cell DExD box RNA helicase 21 (DDX21) as well as to the host cell 7SK small nuclear ribonucleoprotein (7SK snRNP) complex, an important regulator of the positive transcription elongation factor b (P-TEFb). The co-immunoprecipitation of AnkG with DDX21 is probably mediated by salt bridges and is independent of AnkG-7SK snRNP binding, and vice versa. It is known that DDX21 facilitates the release of P-TEFb from the 7SK snRNP complex.

Consistent with the documented function of released P-TEFb in RNA Pol II pause release, RNA sequencing experiments confirmed AnkG-mediated transcriptional reprogramming and showed that expression of genes involved in apoptosis, trafficking, and transcription are influenced by AnkG. Importantly, DDX21 and P-TEFb are both essential for AnkG-mediated inhibition of host cell apoptosis, emphasizing the significance of the interaction of AnkG with both, the DDX21 protein and the 7SK RNA. In line with a critical function of AnkG in pathogenesis, the AnkG deletion C. burnetii strain was severely affected in its ability to inhibit host cell apoptosis and to generate a replicative C. burnetii-containing vacuole. In conclusion, the interference with the activity of regulatory host cell RNAs mediated by a bacterial effector protein represent a novel mechanism through which C. burnetii modulates host cell transcription, thereby enhancing permissiveness to bacterial infection.

Source: PLoS Pathogens 18 (2022)

READ FULL ARTICLE

Inactivation kinetics of Coxiella burnetii during high-temperature short-time pasteurization of milk:

 The Gram-negative, obligate intracellular bacterium Coxiella burnetii is the causative organism of the zoonosis Q fever and is known for its resistance toward various intra and extracellular stressors. Infected ruminants such as cattle, sheep, and goats can shed the pathogen in their milk. Pasteurization of raw milk was introduced for the inactivation of C. burnetii and other milk-borne pathogens. Legal regulations for the pasteurization of milk are mostly based on recommendations of the Codex Alimentarius. As described there, C. burnetii is considered as the most heat-resistant non-sporeforming bacterial pathogen in milk and has to be reduced by at least 5 log10-steps during the pasteurization process. However, the corresponding inactivation data for C. burnetii originate from experiments performed more than 60 years ago. Recent scientific findings and the technological progress of modern pasteurization equipment indicate that C. burnetii is potentially more effectively inactivated during pasteurization than demanded in the Codex Alimentarius. In the present study, ultra-high heat-treated milk was inoculated with different C. burnetii field isolates and subsequently heat-treated in a pilot-plant pasteurizer. Kinetic inactivation data in terms of D- and z-values were determined and used for the calculation of heat-dependent log reduction. With regard to the mandatory 5 log10-step reduction of the pathogen, the efficacy of the established heat treatment regime was confirmed, and, in addition, a reduction of the pasteurization temperature seems feasible.

Source: Marcel Wittwer, Philipp Hammer, Martin Runge, Peter Valentin-Weigand, Heinrich Neubauer, Klaus Henning und Katja Mertens-Scholz, Inactivation kinetics of Coxiella burnetii during high-temperature short-time pasteurization of milk
Frontiers in Microbiology, Vol. 12, 2022

READ FULL ARTICLE

Cover story: A Q fever outbreak on a mixed dairy farm – a one health approach

 A Q fever outbreak on a dairy goat/cattle farm was investigated with regard to the One Health concept. Samples from all domestic animals and the farmer's family were collected, including goats with different reproductive statuses. The serological analysis revealed current infections in goats, whereas cows had ongoing infections. The possible influence of gestation and hormonal status on Coxiella burnetii infection in goats is discussed. A new cattle-associated Coxiella burnetii genotype C16 was identified in vaginal swabs and placentas from ruminants. Feline, canine, and human sera also tested positive for Coxiella burnetii antibodies. We conclude that the cattle herd may have transmitted Coxiella to the pregnant goats, resulting in zoonotic spread of Q fever to cats, dogs, and humans on the affected farm.

Source: Benjamin U. Bauer, Michael R. Knittler, T. Louise Herms, Dimitrios Frangoulidis, Svea Matthiesen, Dennis Tappe, Martin Runge and Martin Ganter
Cover story: A Q Fever Outbreak in a Mixed Dairy Farm - A one Health Approach
Publikation: Multispecies Q Fever Outbreak in a Mixed Dairy Goat and Cattle Farm Based on a New Bovine-Associated Genotype of Coxiella burnetii
Vet. Sci., Volume 8, Issue 11 (November 2021)

READ FULL ARTICLE